Status™ COVID-19/Flu A&B (25 per box | 500 case)

A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens.

• COVID-19
  – Anterior nasal swab specimen − Sensitivity 93.8 %, Specificity 100%
  – Nasopharyngeal − Sensitivity 93.1 %, Specificity 100%

• Flu A – Sensitivity 91.4%, Specificity 95.7%
• Flu B – Sensitivity 87.6%, Specificity 95.9%
• FDA Emergency Use Authorization (EUA)
• Visually read in 15 minutes
• Flocked nasopharyngeal swab for superior specimen collection and patient comfort

*25 per box | 500 case